"Andres Poveda, MD Initia Oncology Hospital Quironsalud Valencia, Spain 5 Live #ASCO20"
4:57
Key Insights on Olaparib maintenance monotherapy for non-germline BRCA1/2-mutated (non-gBRCAm) platinum-sensitive relapsed ovarian cancer (PSR OC) patients (pts): Phase IIIb OPINION interim analysis.
Key Insights on Olaparib maintenance monotherapy for non-germline BRCA1/2-mutated (non-gBRCAm) platinum-sensitive relapsed ovarian cancer (PSR OC) patients (pts): Phase IIIb OPINION interim analysis.
Gynecologic Malignancies Similar Videos
-
Kathleen Moore, MD; Stephenson Cancer Center at the University of Oklahoma; 5Live; #ASCO2021
7:47
-
Addressing Disparities in Cancer Care and Incorporating Precision Medicine for Minority Populations_Gynecologic Malignancies_Cervical Cancer_Rebecca Perkins, MD, MSc
45:52
-
Thomas J. Herzog, MD; University of Cincinnati Cancer Center; 5Live; #ASCO21
8:12